XTLB
Xtl Biopharmaceuticals·NASDAQ
--
--(--)
--
--(--)
1.18 / 10
Underperform
The technical composite registers 1.18/10, evidencing challenging technical structure. Supportive evidence from no significant factors contends with contradictory data from Long Upper Shadow, Marubozu White, MACD Death Cross, Long Lower Shadow, and MACD Golden Cross. Technical evaluation: cautious.
Analysis Checks(0/5)
Long Upper Shadow
Score1/10
Win Rate33.80%
Hist. Signals71
Avg Return-2.04%
Score1/10
Win Rate33.80%
Hist. Signals71
Avg Return-2.04%
MACD Death Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-5.64%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-5.64%
Marubozu White
Score1.83/10
Win Rate42.50%
Hist. Signals40
Avg Return-0.09%
Score1.83/10
Win Rate42.50%
Hist. Signals40
Avg Return-0.09%
Long Lower Shadow
Score1/10
Win Rate34.15%
Hist. Signals82
Avg Return-1.54%
Score1/10
Win Rate34.15%
Hist. Signals82
Avg Return-1.54%
MACD Golden Cross
Score1.07/10
Win Rate22.22%
Hist. Signals9
Avg Return0.74%
Score1.07/10
Win Rate22.22%
Hist. Signals9
Avg Return0.74%
Long Upper Shadow
Score1/10
Win Rate33.80%
Hist. Signals71
Avg Return-2.04%
Score1/10
Win Rate33.80%
Hist. Signals71
Avg Return-2.04%
Long Lower Shadow
Score1/10
Win Rate34.15%
Hist. Signals82
Avg Return-1.54%
Score1/10
Win Rate34.15%
Hist. Signals82
Avg Return-1.54%
MACD Death Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-5.64%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-5.64%
MACD Golden Cross
Score1.07/10
Win Rate22.22%
Hist. Signals9
Avg Return0.74%
Score1.07/10
Win Rate22.22%
Hist. Signals9
Avg Return0.74%
Marubozu White
Score1.83/10
Win Rate42.50%
Hist. Signals40
Avg Return-0.09%
Score1.83/10
Win Rate42.50%
Hist. Signals40
Avg Return-0.09%
What is the current technical signals for XTLB?
- XTLB presents a Underperform setup with a Technical Score of 1.18/10. Key technical indicators highlight an RSI of 62.11 and a MACD of 0.03, with the trend anchored by the 50-Day SMA at 0.84. Traders should monitor key support at 1.00 and resistance at 1.11.
